No abstract available
Keywords:
PD-1; PD-L1; checkpoint inhibitors; lung cancer.
MeSH terms
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / immunology
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / immunology
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
B7-H1 Antigen / antagonists & inhibitors
-
B7-H1 Antigen / immunology
-
Biomarkers, Pharmacological
-
Humans
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / immunology
-
Lung Neoplasms / pathology
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors
-
Programmed Cell Death 1 Receptor / immunology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
B7-H1 Antigen
-
Biomarkers, Pharmacological
-
CD274 protein, human
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab
-
atezolizumab
-
pembrolizumab